Foregen

Website

Foregen Foregen is a non-profit organization founded to research and implement regenerative medical therapies for circumcised males.

Foregen’s work entails:

Negotiating with research institutes in the field of Regenerative medicine to promote dermal Regeneration for the genitally injured;
Organizing research and clinical trials necessary to make regenerative medical applications a reality;
Fund-raising for the clinical trials needed to make regenerative solutions a reality.

Our October research update is out.🔬 Whole-sample reseeding is now underway at our partners' lab in Piešťany, Slovakia. ...
02/11/2026

Our October research update is out.

🔬 Whole-sample reseeding is now underway at our partners' lab in Piešťany, Slovakia. Keratinocytes, which form the outer layer of the tissue, are the last piece of the recellularization stage.
📄 The first scientific paper from the current project is expected within the next month or two.
💚 Thanks to our community, Foregen raised $23,053 in October, and the Research Accelerator Fundraiser is now live. Every $20,000 raised unlocks a new video from inside the lab.

Read or listen to the full update: https://foregen.org/updates/newsletter-november-2026
Support the research: foregen.org/fundraiser

25/10/2026

Nearly $7,000 raised in just under a week! Thank you. Your support is helping us take the tissue samples from ECM to living tissue. Next stop: $20K, which unlocks a new look inside the lab. foregen.org/fundraiser

20/10/2026

Nearly $2,000 has been raised in just the first few days of our fundraiser!

Those who give $250 or more will receive a one-of-a-kind Foregen challenge at the end of the campaign.

Your contributions make our project a reality.

Learn more: foregen.org/fundraiser

19/10/2026

Today we’re launching the Research Accelerator Fundraiser: $100,000 to finish recellularization and move toward tissue maturation.

Every $20,000 unlocks a new video from inside the lab. Give $250+ and get a challenge coin made for this campaign!

Link in bio.

18/10/2026

Today we’re launching the Research Accelerator Fundraiser: $100,000 to finish recellularization and move toward tissue maturation.

Every $20,000 unlocks a new video from inside the lab. Give $250+ and get a challenge coin made for this campaign!

foregen.org/fundraiser

Two scientific papers based on our current research project are in development. The first, on a specific aspect of decel...
07/10/2026

Two scientific papers based on our current research project are in development. The first, on a specific aspect of decellularization, is in preproduction and could be published within one to two months.

At the end of September, a small Foregen team visited our research partners' laboratory in Piešťany, Slovakia, to review progress and plan next steps. While there, we interviewed Dr. Stanislav Žiaran and Chief Bioengineer Ján Kováč and recorded new footage in the lab, which we'll release in the coming months.

The rat implantation study is also complete. Every sample was explanted in one piece with no issues observed, and histological analysis is underway.

Read the full update:

October 2026 research update: a decellularization paper in preproduction, a site visit to our partner lab in Slovakia, and implant study results.

28/09/2026

Foregen conducts comprehensive testing on decellularized matrices to guarantee they are free from DNA, toxins, bacteria, and microbes. This rigorous process ensures the safety and efficacy of our regenerative tissue research for future recipients.

26/09/2026

While decellularization is a critical step, it does not fully address the challenges of restoring complex tissue structures. Achieving true three-dimensionality requires further advanced regenerative techniques beyond initial decellularization.

24/09/2026

Foregen's bioengineers are preparing decellularized fo****in samples for regenerative research. Sourced from cadavers, these samples are crucial for restoring neural and vascular infrastructure.

21/09/2026

Foregen's work has significantly advanced the global understanding of regenerative medicine over the past two decades. We have shifted from a skeptical environment to one of broad support, evidenced by numerous expressions of gratitude. This progress highlights our role in fostering hope through cutting-edge regenerative tissue research.

Address

Piestany
921 01

Alerts

Be the first to know and let us send you an email when Foregen posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share